Provexis Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
PXS
- Investments
-
2
- Share Price
-
$0.01
- (As of Wednesday Closing)
Provexis General Information
Description
Provexis PLC is engaged in developing, licensing, and selling the proprietary, scientifically backed Fruitflow heart-health functional food ingredient for the globally functional food sector. The extract is available in two formats: a syrup and a powder, and it can be included in a broad range of food, beverage, and dietary supplement formats.
Contact Information
Website
www.provexis.comCorporate Office
- 2 Blagrave Street
- Berkshire
- Reading RG1 1AZ
- England, United Kingdom
Corporate Office
- 2 Blagrave Street
- Berkshire
- Reading RG1 1AZ
- England, United Kingdom
Provexis Stock Performance
As of 18-Nov-2026, Provexis’s stock price is $0.01. Its current market cap is $26.5M with 2.35B shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $0.01 | $26.5M | 2.35B | 519K |
Provexis Financials Summary
As of 31-Mar-2026, Provexis has a trailing 12-month revenue of $1.69M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 31,824 | 31,824 | 12,348 | 16,415 |
| Revenue | 1,694 | 1,694 | 1,648 | 1,008 |
| EBITDA | (685) | (685) | (576) | (758) |
| Net Income | (674) | (674) | (577) | (737) |
| Total Assets | 1,706 | 1,706 | 1,309 | 629 |
| Total Debt | 0 | 0 | 0 | 0 |
Provexis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Provexis Patents
Provexis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0502985-D0 | Therapeutic uses of tomato extracts | Inactive | 14-Feb-2005 | ||
| ES-2204130-T3 | Anti-thrombosis agents. | Inactive | 24-Apr-1998 | ||
| EP-1334728-A2 | Antithrombotic agents | Inactive | 24-Apr-1998 | ||
| EP-1334728-A3 | Antithrombotic agents | Inactive | 24-Apr-1998 | A61K36/81 |
Provexis Signals
Provexis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Provexis Acquisitions (2)
Provexis’s most recent deal was a Merger/Acquisition with Science in Sport for . The deal was made on 24-Jun-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Science in Sport | 24-Jun-2011 | Merger/Acquisition | Food Products | ||
| Nutrinnovator | 01-Jun-2005 | Merger/Acquisition | Food Products |
Provexis ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Provexis Exits (1)
Provexis’s most recent exit was on 24-Jun-2011 from Science in Sport. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Science in Sport | 24-Jun-2011 | Completed |
|
Provexis Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nutrinnovator | London, United Kingdom | 2002 |
Provexis FAQs
-
When was Provexis founded?
Provexis was founded in 1999.
-
Where is Provexis headquartered?
Provexis is headquartered in Reading, United Kingdom.
-
What is the size of Provexis?
Provexis has 3 total employees.
-
What industry is Provexis in?
Provexis’s primary industry is Beverages.
-
Is Provexis a private or public company?
Provexis is a Public company.
-
What is Provexis’s stock symbol?
The ticker symbol for Provexis is PXS.
-
What is the current stock price of Provexis?
As of 18-Nov-2026 the stock price of Provexis is $0.01.
-
What is the current market cap of Provexis?
The current market capitalization of Provexis is $26.5M.
-
What is Provexis’s current revenue?
The trailing twelve month revenue for Provexis is $1.69M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process